Tag: Sleep & Respiratory Care
Philips targets innovation, trust
February 11, 2026Liz Beaulieu, Editor
AMSTERDAM – In a key post-recall milestone, Philips says it has more than doubled its number of 510(k) clearances from the U.S. Food and Drug Administration (FDA) over the past two years.
During a recent conference call to discuss fourth quarter and full-year financial results, Roy Jakobs reiterated that Philips continues “to address the consequences of the Respironics recall” and “relentlessly work toward resolution of the FDA warning letter issued...
Philips says it’s maintaining momentum with third quarter results
November 4, 2025HME News Staff
AMSTERDAM – Royal Philips’ Connected Care business, which includes Sleep & Respiratory Care, saw comparable sales growth of 5.1% in the third quarter of 2025.
Adjusted EBITA margin improved 410 bps to 11.4%, driven by increased sales and productivity, partially offset by tariffs.
The company, as a whole, saw sales of EUR 4.3 billion for the third quarter of 2025, a 3% comparable increase.
Other results for the Group:
Comparable...
ResMed names new sleep lead
June 28, 2022HME News Staff
SAN DIEGO – ResMed has promoted Lucile Blaise to president of its global Sleep & Respiratory Care business effective July 1. She is currently the company’s vice president of Sleep & Respiratory Care for Western Europe. “I’m thrilled that Lucile – one of Europe’s leading champions of digital health innovation and adoption, as well as data privacy and security – has accepted this promotion to lead ResMed’s global Sleep & Respiratory Care business,”...